How to Apply to Ferrer

Key Takeaways

Ferrer Internacional SA is a privately held, family-owned (Ferrer family since 1959), B Corp certified pharmaceutical company headquartered in Sant Cugat del Vallès (Barcelona), with a Murcia manufacturing plant and 21 international subsidiaries.
CEO Mario Rovirosa Escosura has led the company since 2017, executing a deliberate pivot from generics and primary-care cardiovascular toward specialty pharma in neurological disorders, rare diseases, and oncology.
The company uses a custom Spanish-language careers portal at ferrer.com — not Workday, SuccessFactors, Greenhouse, or any standard commercial ATS.
Recent strategic moves include the Cassiopea acne licensing partnership, the JCR Pharmaceuticals (Japan) collaboration on hereditary angioedema (HAE) portfolio expansion, and substantial investment in an ALS pipeline featuring intravenous and oral edaravone formulations advancing in 2024 and 2025.
Hiring is concentrated in clinical development, regulatory affairs, medical affairs, market access, scientific advisor and MSL roles, hospital and specialty commercial roles in international subsidiaries, and supporting quality, manufacturing, and corporate functions.
Spanish (and to a lesser extent Catalan) is the primary working language at Sant Cugat headquarters; English is used for global cross-functional work and international subsidiary coordination. C1 or C2 Spanish is effectively required for most Spain-based roles.
The B Corp identity and purpose-driven mission language are load-bearing in interviews. Candidates who engage authentically with this framing significantly outperform those who do not.
Compensation is competitive within the Barcelona pharma market, on par with Almirall, Esteve, and Rovi, and modestly behind the largest international multinationals operating in Spain.
Spanish labor law context applies to Spain-based roles: chemical industry convenio colectivo, CCOO and UGT union presence (especially at Murcia and in some headquarters functions), standard 22 to 23 days of paid vacation, three-to-six-month trial period for indefinite contracts.
Interview process typically runs six to ten weeks with a recruiter screen, hiring manager interview, panel round, optional case study or technical exercise, and a final senior-leadership conversation for senior roles.

About Ferrer

Ferrer Internacional SA is a privately held, family-owned pharmaceutical company headquartered in Sant Cugat del Vallès, a suburb of Barcelona, with a manufacturing plant in Murcia and 21 international subsidiaries across Europe, Latin America, North America, the Middle East, and Asia. The company employs approximately 1,800 people worldwide, with the majority concentrated in Spain across the Sant Cugat corporate campus, the Murcia production site, and the Barcelona-area research operations. Ferrer was founded in 1959 by the Ferrer family and remains under family ownership today, a structural fact that shapes hiring, compensation, and strategic decision-making in ways that publicly traded competitors like Almirall, Esteve, Grifols, or Rovi simply cannot replicate. The company that interviews you in 2026 is not the company that existed a decade ago. Through the 1990s and 2000s, Ferrer was largely a generics manufacturer with a strong cardiovascular franchise, a regional Iberian footprint, and a reputation as a competent but unremarkable mid-tier Spanish pharma. Beginning around 2018, under CEO Mario Rovirosa Escosura — who took the chief executive role in 2017 — Ferrer executed a deliberate pivot away from generics and primary-care cardiovascular toward specialty pharma in three therapeutic areas: neurological disorders, rare diseases, and oncology. That strategic shift is the single most important context for any candidate to understand. Roles that involve specialty therapeutic areas, orphan drug development, hospital and specialist commercial channels, scientific affairs, and patient advocacy are growing. Roles tied to legacy generics manufacturing and primary-care commercial are not. Ferrer is also a certified B Corporation, a designation it achieved as part of a formal commitment to social and environmental performance and one that the company markets prominently in recruiting materials and on its careers site. The B Corp framing is not decorative — it shows up in interview questions, in performance management language, in sustainability reporting, and in a corporate purpose statement (the company describes its mission as making a positive impact in society) that appears in nearly every job posting. Candidates who frame their motivation purely in terms of compensation or career velocity, without engaging with the purpose dimension, consistently underperform in interviews. This is true at Ferrer in a way that it is not at most of its Spanish pharma peers. The specialty pivot has been executed in part organically and in part through licensing and partnership deals. Recent visible moves include the licensing partnership with Cassiopea covering acne therapeutics, the collaboration with JCR Pharmaceuticals of Japan on hereditary angioedema (HAE) portfolio expansion, and the substantial investment in an amyotrophic lateral sclerosis (ALS) pipeline, with intravenous and oral edaravone formulations advancing through development in 2024 and 2025. The ALS program is a particularly important talking point because it is both the most visible scientific bet the company has made and a meaningful signal of where Ferrer wants to be positioned in five years: a credible, mid-sized specialty player in difficult neurological and rare-disease indications, not a primary-care commodity supplier. For candidates, the practical implication is that Ferrer is hiring most actively in 2026 in clinical development, regulatory affairs, medical affairs, market access, scientific advisor and MSL roles, hospital and specialty commercial in international subsidiaries, and the supporting quality, manufacturing, supply chain, and corporate functions that scale with a specialty business. Generics-only candidates and cardiovascular primary-care commercial candidates can still find roles, but they should expect a more selective process and should be prepared to articulate how their experience translates to the new strategic direction. The Spanish-language work culture is real and load-bearing. Spanish (and to some extent Catalan in the Sant Cugat headquarters) is the primary working language across most domestic functions, with English reserved for global cross-functional work, international subsidiary coordination, and regulatory submissions to the EMA and other non-Spanish authorities. Candidates without working Spanish should not assume Ferrer is a viable option for a Spain-based role unless the posting explicitly states otherwise; international roles in subsidiaries (Mexico, Brazil, Germany, Italy, the United States, the United Kingdom, and others) operate in the local language with English as the bridge.

ATS System: Custom Ferrer Careers Portal (Spanish-Language)

Ferrer operates a custom Spanish-language careers portal hosted on its corporate domain rather than using Workday, SuccessFactors, Greenhouse, Lever, or another standard third-party ATS. The portal handles job posting, application intake, candidate accounts, and initial screening workflows. Behind the scenes, Ferrer's HR systems integrate with Spanish payroll and benefits providers and with the country-specific HR systems used in the 21 international subsidiaries. The portal is functional but less polished than the leading commercial ATS platforms — expect a Spanish-first user experience, mobile-friendly but not mobile-optimized layouts, and occasional minor friction in the application form. Save a copy of every long-text answer you submit, since the system does not consistently email a complete record of your responses.

Submit your CV as a clean, single-column or simple two-column PDF without text boxes, embedded images (other than an optional headshot), or unusual fonts. Standard PDFs parse well; heavily designed templates can scramble your skills and dates in the parsed view that reviewers see.
Use exact keywords from the job description where they apply honestly to your background. The portal supports keyword filtering by recruiters, so a CV that mirrors the language of the posting — specific therapeutic areas, regulatory frameworks, technical platforms, software tools — surfaces more reliably in candidate searches.
Complete every field in the application form, including optional ones. Empty fields can flag your application for follow-up or set it aside in the queue. Self-rated language proficiency, work authorization status, notice period, and salary expectations are all reviewed by the recruiter before scheduling a screening call.
Apply only once per role. The portal deduplicates by email address and creates a single candidate record across all your applications to Ferrer, so a duplicate submission for the same requisition does not improve your chances. If you need to update your CV, withdraw and resubmit cleanly through your candidate portal.
If you applied previously and were not selected, you can re-apply for new roles with an updated CV. The portal retains your prior history, so be prepared for the recruiter to reference previous interview feedback. A brief cover letter or motivation paragraph acknowledging what has changed in your background since the last application is appreciated.
Save your application materials offline. The portal occasionally has session timeouts or maintenance windows, and a complete copy of your CV, cover letter, and any long-text responses gives you a backup in case of submission issues.

Interview Culture

Ferrer's interview culture reflects the intersection of three forces: family-owned mid-sized European pharma conventions, the specialty therapeutic pivot under CEO Mario Rovirosa Escosura, and the certified B Corp framing that the company has formally embedded in its purpose statement. The combined result is interviews that are professional, scientifically and commercially serious, conversational rather than adversarial, and unusually focused on motivation and purpose alignment. Candidates who have only interviewed at large multinationals like Pfizer, Novartis, or Roche, or at Spanish public-sector institutions, sometimes underestimate how much weight Ferrer places on the cultural and purpose dimensions of the conversation. The screening call is conducted in Spanish for Spain-based roles, in the local language for international subsidiary roles, and in English where genuinely warranted. Recruiters ask directly about your motivation for choosing Ferrer over other pharma employers, with particular interest in whether you have engaged with the B Corp framework, the specialty pivot strategy, the recent partnership announcements (Cassiopea, JCR Pharmaceuticals, the ALS pipeline), and the family ownership context. Generic answers about 'looking for a new challenge' or 'wanting to grow my career' are received politely but do not advance you; specific, informed answers grounded in the company's actual situation do. Hiring manager and panel rounds are scientifically and functionally rigorous. For R&D and medical affairs, expect probing questions about therapeutic-area depth, with particular interest in neurological disorders, rare diseases, and oncology. For regulatory affairs, expect detailed discussion of EMA procedures, the AEMPS (the Spanish Agency of Medicines and Medical Devices), and your direct experience with marketing authorization applications, variations, paediatric investigation plans, and orphan drug designations. For commercial and market access, expect realistic discussion of single-payer European reimbursement dynamics, hospital tendering, regional health authority negotiations within the Spanish autonomous community system, and the specific dynamics of specialty product launches with limited prescriber populations. Interviews are bilingual in practice for most professional roles. The conversation typically begins in Spanish, switches to English when discussing international experience or technical topics where English is the working language, and may switch back to Spanish for cultural fit and motivation discussion. Interviewers will calibrate their language to your stated proficiency, but they will also be assessing whether your CV claims (C1 in English, B2 in Spanish, etc.) match your actual conversational comfort. Overstating language proficiency on your CV is a common error and is uncovered quickly. The family-owned context shows up in subtle but meaningful ways. The Ferrer family remains involved in governance through the board, and the corporate culture emphasizes long-term decision-making, employee tenure, and a less aggressive performance-management approach than is typical at large publicly traded pharma. Interviewers ask about your interest in stable long-term employment versus rapid career hopping, and candidates who present a track record of two-year stints across many employers face skeptical questioning about commitment. This is not a hard exclusion — talented candidates with shorter tenures are routinely hired — but it is a meaningful filter. The company's labor relations context is also worth understanding. Ferrer's Spanish workforce is covered by the chemical industry national collective bargaining agreement (convenio colectivo) and has CCOO and UGT union representation, particularly visible at the Murcia manufacturing plant and in some headquarters functions. This is normal and expected for Spanish industrial-scale employers; it is not a red flag. Compensation and benefits at Ferrer are generally regarded as competitive within the Barcelona pharma market, on par with Almirall, Esteve, and Rovi, and modestly behind the largest international multinationals like Roche, AstraZeneca, and Boehringer Ingelheim that maintain large Spanish operations. Feedback loops between interview rounds are reasonable for a company of Ferrer's size, with most candidates hearing back within five to ten business days after each stage. The overall process from first application to offer typically runs six to ten weeks, somewhat longer than fast-moving startups but in line with the broader European pharma industry. Compensation discussions happen in the screening call and again at offer stage; Ferrer is generally direct about ranges in euros and structures offers under Spanish labor law with the standard variable bonus, benefits, and trial period clauses.

What Ferrer Looks For

Genuine alignment with the purpose-driven, B Corp identity. Ferrer screens hard for candidates whose motivation engages with the company's social and environmental commitments, not just compensation and career velocity. Performative answers are detected; authentic engagement with the purpose narrative is consistently rewarded across all functions and seniority levels.
Therapeutic-area depth in neurological, rare disease, or oncology indications. Even for non-R&D roles, candidates who can speak credibly about specialty therapeutic areas — the science, the patient populations, the prescriber landscape, the regulatory pathways — outperform candidates who can only speak about primary care or generics. The strategic pivot is the central context, and aligning with it is the single highest-leverage interview move.
Working Spanish proficiency for Spain-based roles. C1 or C2 Spanish is effectively required for any Sant Cugat or Murcia-based role outside of a small number of explicitly international or English-medium positions. This is non-negotiable for most positions; international candidates without Spanish are routed to subsidiary roles in markets where their language profile fits.
Track record of regulatory rigor in European and global frameworks. EMA experience, AEMPS experience, ANVISA, COFEPRIS, FDA, and other major regulatory authorities appear as plus factors depending on the role. Specific experience with orphan drug designations, paediatric investigation plans, marketing authorization applications, post-authorization safety studies, and risk management plans is meaningful for relevant roles.
Commitment to long-term employment. The family-owned, stable-tenure cultural model means the company genuinely prefers candidates who present a credible multi-year horizon. Two- and three-year tenures repeated across many prior employers are scrutinized; longer tenures with internal progression read very well. This is not a hard exclusion but it is a real filter.
Cross-functional collaboration capability. The mid-sized scale of Ferrer means functions are smaller and more interconnected than at large multinationals. Candidates who have demonstrated the ability to work effectively across R&D, Medical Affairs, Regulatory, Commercial, Market Access, Quality, and Operations boundaries do well. Pure single-function specialists who struggle to engage cross-functionally do less well.
Cultural fit with a Catalan-headquartered, internationally minded pharma. The Sant Cugat campus is unmistakably Catalan in many surface ways (Catalan signage, occasional Catalan in informal conversation, regional holiday calendar, local food culture in the canteen), while the working language is Spanish and the strategic outlook is global. Candidates who appreciate that combination tend to integrate well; candidates who treat Catalonia as an obstacle or an irrelevance tend not to.
Comfort with Spanish labor law conventions. Spanish employment contracts, the chemical industry convenio colectivo, the role of CCOO and UGT in worker representation, the standard 22 to 23 days of paid vacation, the trial period dynamics, and the indefinite-contract default are all part of the normal employment context at Ferrer. Candidates who understand and accept this framework integrate more smoothly than those who try to negotiate around it.

Frequently Asked Questions

What ATS does Ferrer Internacional use to manage applications?

Ferrer operates a custom Spanish-language careers portal hosted on its corporate ferrer.com domain rather than using Workday, SuccessFactors, Greenhouse, Lever, or any other standard commercial ATS. The portal handles job posting, application intake, candidate account management, and initial screening workflows. It is functional and mobile-friendly but Spanish-first throughout, so candidates without working Spanish should expect friction in the application experience for Spain-based roles. Save a copy of every long-text answer you submit, since the system does not consistently email a complete record of your responses.

Is Ferrer still hiring in 2026 given its strategic pivot?

Yes, actively. The shift from generics and primary-care cardiovascular toward specialty pharma in neurological disorders, rare diseases, and oncology has changed the composition of hiring rather than reduced its volume. Roles in clinical development, regulatory affairs, medical affairs, market access, scientific advisor and MSL functions, hospital and specialty commercial in international subsidiaries, and the supporting quality, manufacturing, supply chain, and corporate functions are all hiring. Generics-only and cardiovascular primary-care commercial candidates can still find roles but should expect a more selective process.

Are Ferrer roles based in Sant Cugat del Vallès, or is remote work available?

The majority of corporate, R&D, headquarters, and specialty commercial roles are based at the Sant Cugat del Vallès campus near Barcelona, with a hybrid working model that typically involves two to three days per week in the office. Manufacturing, quality, and operations roles tied to the Murcia plant are based on-site at Murcia. The 21 international subsidiaries handle their own local hiring with local working arrangements. Fully remote roles exist but are exceptions rather than the norm and are usually called out explicitly in the job posting.

Does Ferrer sponsor work authorization for international candidates?

Ferrer does sponsor Spanish work authorization for senior and specialized roles where the talent pool is narrow, particularly in scientific, regulatory, clinical, and specialty therapeutic-area positions. For most mid-level positions, the company prefers candidates with existing unrestricted work rights in Spain or the European Union. International candidates outside the EU should expect longer overall timelines and should state their work authorization status clearly in the application. EU citizens can work in Spain without sponsorship under freedom-of-movement provisions.

What does the Ferrer interview process look like end-to-end?

A typical loop runs six to ten weeks and includes a recruiter screening call, a hiring manager interview, a panel or cross-functional round (sometimes on-site at Sant Cugat), an optional case study or technical exercise for senior roles, a final conversation with senior leadership for director-level and above positions, reference checks, and a written offer under Spanish labor law. The process is professional, scientifically rigorous, and unusually focused on motivation and purpose alignment compared to peer pharma employers.

Do I need to speak Spanish to work at Ferrer?

For any role based in Sant Cugat del Vallès or Murcia, working Spanish proficiency at the C1 or C2 CEFR level is effectively required. A small number of explicitly international or English-medium roles exist but they are exceptions. For roles in the 21 international subsidiaries (Mexico, Brazil, Germany, Italy, the United Kingdom, the United States, and others), the local language plus working English is the standard expectation, with Spanish as a useful but not required additional asset. Catalan proficiency is a meaningful plus for Sant Cugat headquarters roles but is not strictly required for most positions.

How does compensation compare to other Spanish pharma employers?

Compensation at Ferrer is generally regarded as competitive within the Barcelona pharma market, broadly on par with Almirall, Esteve, and Rovi, and modestly behind the largest international multinationals such as Roche, AstraZeneca, Novartis, and Boehringer Ingelheim that maintain large Spanish operations. Compensation is paid in euros under the Spanish chemical industry collective bargaining agreement framework and typically includes base salary, a variable bonus targeted as a percentage of base, comprehensive benefits, the standard 22 to 23 days of paid vacation, and clearly defined trial period clauses for new hires.

What is the family ownership context, and does it affect my work life?

Ferrer has been owned by the Ferrer family since its founding in 1959 and remains under family ownership today. The family is involved in governance through the board, and the cultural effects of this ownership structure are real: longer-term decision-making horizons, less quarterly-earnings pressure than at publicly traded peers, a generally less aggressive performance-management posture, and an emphasis on employee tenure that rewards multi-year commitment. Day-to-day work life is professional and structured similarly to other mid-sized European pharma employers, but the underlying strategic patience is genuinely different from publicly traded competitors.

How important is the B Corp identity in interviews?

Very important. Ferrer's certified B Corp status and its purpose-driven mission language are not decorative — they show up directly in interview questions, in performance management framing, and in candidate evaluation. Candidates who can speak authentically about how Ferrer's social and environmental commitments align with their own motivations consistently advance further than candidates who treat the B Corp framing as marketing. This is not about repeating buzzwords; interviewers can detect performative versus genuine engagement reliably.

What is the union and labor relations context at Ferrer?

Ferrer's Spanish workforce is covered by the chemical industry national collective bargaining agreement (convenio colectivo del sector químico) and has CCOO (Comisiones Obreras) and UGT (Unión General de Trabajadores) union representation, particularly visible at the Murcia manufacturing plant and in some headquarters functions. This is normal and expected for Spanish industrial-scale employers and is not a red flag. Worker representation and the convenio framework set baselines for working hours, overtime, vacation, severance, and other employment conditions, which provides predictability for both the company and employees.

What should I know about the ALS pipeline if I am applying for an R&D or medical affairs role?

Ferrer's ALS pipeline is one of the most visible scientific bets the company has made and is a meaningful talking point in interviews for relevant roles. The program centers on intravenous and oral edaravone formulations advancing through development in 2024 and 2025. ALS is a difficult indication with a small patient population, complex regulatory pathways including orphan drug designation, and a sensitive patient advocacy landscape. Candidates with relevant neurological, rare disease, or orphan drug experience should be prepared to discuss the program substantively, and candidates without direct experience should at minimum understand the program exists and align it to the broader specialty pivot narrative.

How should I prepare for the case study or technical exercise if one is requested?

Case studies and technical exercises are typically take-home with three to seven days to complete and are presented back to the hiring panel in a 30 to 45 minute session with Q and A. For commercial and market access roles, expect a market opportunity assessment, launch plan outline, or payer dossier excerpt focused on a specialty therapeutic area. For technical R&D, manufacturing, and quality roles, expect a deviation investigation write-up, a CMC document review, or a study design discussion. The exercise is not designed to test trivia; it is designed to evaluate how you structure thinking and communicate decisions. Lean into clarity, intellectual honesty about assumptions and limitations, and a presentation style that respects the panel's time.

How to Apply to Ferrer

Key Takeaways

About Ferrer

ATS System: Custom Ferrer Careers Portal (Spanish-Language)

Interview Culture

What Ferrer Looks For

Frequently Asked Questions

Open Positions

Related Resources

Similar Companies

Related Articles

Sources